BiosimilarsEU

Official Twitter account for the Biosimilar Medicines Group, a sector group of @medicinesforEU #patients #quality #value #sustainability RTs not endorsement

[BiosimilarsEU @biosimilarsEU]

Industry Welcomes the European Commission Workshop on the Uptake of Biosimilar Medicines https://t.co/1OJOcXZ1Cy… @EFPIA @EuropaBio

[Medicines for Europe @medicinesforEU]

Biosimilars have increased access for patients in over 60 countries around the world. #AccessHealth

[BioSim @BioSim_es]

📹 #VÍDEO Medicamentos #biosimilares: una oportunidad para el sistema https://t.co/5ks9TE5sJK vía @medicinesforEU

[Internal Market, Industry, Entrepreneurship & SMEs @EU_Growth]

How do #biosimilar medicines affect the market? New report: https://t.co/DuBIDs0Yq2 @IMSHealth

[Medicines for Europe @medicinesforEU]

Prof Vulto speaking at the @EU_Commission #biosimilars workshop "savings potential of biosimilars is underused"

[Medicines for Europe @medicinesforEU]

.@EU_Commission #Biosimilars Workshop today in Brussels: Prof. Vulto: "we need to build trust into biosimilars"

[Medicines for Europe @medicinesforEU]

EFCCA Vice President M. Salvatore: "the patient must always be in the center of the decision process" at @EU_Commission #Biosimilars today

[Medicines for Europe @medicinesforEU]

Ecco survey 2015: "definitely an increase in the believe that reference products and biosimilars are interchangeable" Gecse at EC workshop

[Medicines for Europe @medicinesforEU]

All hospitals in Holland keep records of the medicines the patients got says Prof Vulto at EC biosimilars workshop

[Medicines for Europe @medicinesforEU]

Dr Cummings at EC #biosimilars Workshop today: "we extrapolate data every day"

[Medicines for Europe @medicinesforEU]

Dr Cummings: "We managed to convince all patients to switch to biosimilar infliximab. Patient dialogue with their doctor is key" EC workshop

[BiosimilarsEU @biosimilarsEU]

Biosimilar infliximab and etanercept medicines are now available to increase access to biopharmaceuticals for rheumatology #EULAR2016

[BiosimilarsEU @biosimilarsEU]

PRESS RELEASE | Biosimilar Medicines for Rheumatologists: Bridging the Gap between Regulatory Science and Medical Societies #biosimilars

[Medicines for Europe @medicinesforEU]

What is the value of generic, biosimilar and value added #medicines? Learn more with us at #IGBAEGA2016 #hcsmeu

[Medicines for Europe @medicinesforEU]

Almost ready here! Join us in 15 minutes #AskJacekGlinka

[✿ Doris Casares @DorisCasares]

They will be there! @patientpowereu @Birgitpower @eupatientsforum @TuLupus #AskJacekGlinka https://t.co/1TPkbCnY3v

[AMEGI @AMEGI_MX]

IGBA- Medicamentos para Europa 2016 Conferencia Anual que se llevará a cabo en Croacia el próximo junio 8-10, 2016. https://t.co/Hd1z5YDMUX

[Healthcare Hashtag Project @healthhashtags]

Top Influencers of #ebgbios16: @medicinesforeu @sandoz_global @biosimilarseu @fwpharma @us_fda Real-time Analytics: https://t.co/1pZKLml3s7

[Medicines for Europe @medicinesforEU]

Join the Tweetup with @medicinesforEU President Jacek Glinka on the 2nd June 2016 (13.00-13.45 ) #AskJacekGlinka

[Generics bulletin @Genericbulletin]

Take our #Generics & #Biosimilars Industries survey - results at @medicinesforEU and #IGBA conference #IGBAEGA2016